Previous studies indicated high frequency of abuse in families and its consequences. Considering the importance of interventions such as educational interventions, in order to increase women's abilities to prevent abusive behaviors, the current research aims to determine the impact of an Liberty program on prevention of violence against women and propose solutions for less damages and consequences.
Full Title of Study: “Study of Liberty Program on Women’s Health and Intimate Partner Violence: Multinational, Open, Randomised, Controlled Clinical Study”
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: Single (Outcomes Assessor)
- Study Primary Completion Date: June 2017
- Behavioral: Liberty Program
Arms, Groups and Cohorts
- Experimental: Liberty Group
- Weekly intensive support group for women with children who have suffered or are still suffering from domestic abuse (DA).
- No Intervention: Control group
Clinical Trial Outcome Measures
- Quality of Life measured by SF 36 Scale
- Time Frame: Change from baseline in SF 36 Scale at 6 months
- Self-Esteem measured by Rosenberg Self-Esteem Questionnaire
- Time Frame: Change from Baseline in Rosenberg Self-Esteem Questionnaire at 6 months
Participating in This Clinical Trial
- Be married,
- Be under the aegis of Foundation at least for a year,
- Have at least one child.
- Not participating in two educational sessions,
- Not being interested in continuing the cooperation.
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 60 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Macmillan Research Group UK
- Goldington Family Center, UK
- Provider of Information About this Clinical Study
- Overall Official(s)
- Bharat B Chaudhari, MA, Study Director, Sonal Foundation, India
- Paramjeet S Makkar, MD, Study Director, Vinita Nursing Home, India
- Michael Howe, MA, Study Chair, Goldington Family Centre, UK
- Avinash Mishra, MA, Study Director, Shanghai University, China
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.